trending Market Intelligence /marketintelligence/en/news-insights/trending/jg3peqir82xwlprb0d-lda2 content esgSubNav
In This List

CytoDyn raises $9.9M through private placement

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


CytoDyn raises $9.9M through private placement

Vancouver, Wash.-based CytoDyn Inc. raised approximately $9.9 million via the sale of 19,823,260 units at 50 cents apiece.

Each unit was made up of a common share and a warrant to purchase an additional stock at 75 cents each.

CytoDyn is developing treatments for HIV.